A case of irAE gastritis caused by cemiplimab administration.

Cemiplimab-induced immune-related gastritis can be diagnosed based on its characteristic endoscopic and histopathological features, similar to irAE gastritis caused by other immune checkpoint inhibitors.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2026-02-01
DOI
https://doi.org/10.20407/fmj.2025-022
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A case of irAE gastritis caused by cemiplimab administration.

Haruki Nishizawa, Chiaki Oshima, Mayuko Ito, Yusuke Shimizu et al.
PubMed
Cancer Immunotherapy and Biomarkers
article

A case of irAE gastritis caused by cemiplimab administration.

Haruki Nishizawa, Chiaki Oshima, Mayuko Ito, Yusuke Shimizu, Akiko Ohwaki, Kyohei Takada, Yutaro Sato, Kurumi Isomura, Ryoko Ichikawa, Sayaka Otani
article en

Abstract

Cemiplimab-induced immune-related gastritis can be diagnosed based on its characteristic endoscopic and histopathological features, similar to irAE gastritis caused by other immune checkpoint inhibitors.

PubMedVol. 12(1)
Fujita Health University (JP)
Good health and well-being
Openalex Percentile: Top 69%
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A case of irAE gastritis caused by cemiplimab administration. — Haruki Nishizawa, Chiaki Oshima, et al. · PubMed (2026) | TGRS Research Map | TGRS